CPT2 p.Phe417=
c.1251C>T · rs576822710 · VCV741863
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP 0.28 | GERP -0.69, phastCons 0.028 |
| Overall | ||
| CADD | 8.579 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Admixed Americangrpmax | 0.015% | 6,669 |
| African / African-American | 0.0107% | 9,380 |
| South Asian | 0.00329% | 30,359 |
| Remaining individualsnot grpmax-eligible | 0.0032% | 31,256 |
| East Asian | 0.00223% | 44,884 |
| European (non-Finnish) | 0.0011% | 90,770 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CPT2
- Protein
- p.Phe417=
- Coding
- c.1251C>T
- MANE Select
- NM_000098
- dbSNP
- rs576822710
- Type
- single nucleotide variant
- Location
- chr1:53210925 (GRCh38)
- Gene constraint
- LOEUF 1.038 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 94.52
Disease context
carnitine palmitoyltransferase II deficiency — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Carnitine palmitoyltransferase II deficiency (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- All ages
Similar variants
- CPT2 p.Phe417Leu Uncertain significance ★ ⚠ same residue
- CPT2 c.340+1G>C Pathogenic/Likely pathogenic ★★ same condition
- CPT2 c.340+5G>A Likely pathogenic ★★ same condition
- CPT2 c.341-2A>G Pathogenic/Likely pathogenic ★★ same condition
- CPT2 p.Ala67Gly Likely pathogenic ★★ ⚠ same condition
- CPT2 p.Arg124Gln Likely pathogenic ★★ same condition
- CPT2 p.Arg124Ter Pathogenic/Likely pathogenic ★★ same condition
- CPT2 p.Arg151Gln Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cpt2-p-phe417 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown